Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 08, 2026
TickeronGET DAILY SIGNALS
Arm Holdings (ARM): Could Shares Reach the $275 Analyst Average, a +57% Move?

Arm Holdings (ARM): Could Shares Reach the $275 Analyst Average, a +57% Move?

Key Takeaways

  • The central target of $275 is the arithmetic mean of 11 recent, individually verified analyst price targets, rounded to a clean level; it is not an official published consensus.
  • Arm Holdings plc (ARM), the British semiconductor and CPU intellectual-property designer, last traded near $174.62, so reaching $275 implies roughly a 57% move.
  • Recent analyst targets span a wide band from $212 (Morgan Stanley) to $330 (Mizuho), while the broader analyst universe ranges from about $125 to $500.
  • Supporting factors include a 50% jump in licensing revenue, data-center royalties that doubled, and the new Arm AGI CPU entering production.
  • Key risks are slowing royalty growth tied to a weak smartphone market, an elevated valuation, and Qualcomm-related royalty uncertainty.
  • The required move is very large relative to the current price, reflecting meaningful disagreement about how quickly Arm's AI-driven growth offsets a soft handset cycle.
  • For more detail on this ticker, explore its Major News, Today's Price Move, Forecast, and Earnings pages.
  • You can also explore Trending AI Robots for AI-driven ways to monitor opportunities and shifting market trends.

Analyst Price Targets and Consensus View

Arm Holdings is a stock, not an ETF, and it carries unusually wide analyst coverage with equally wide opinions. Across recent, individually verifiable price targets following the company's November 2026 earnings, the calculated mean lands near $275. Individual post-earnings marks include $326 (Evercore ISI), $330 (Mizuho), $325 (Barclays), $300 (RBC Capital), $270 (UBS and Piper Sandler), $255 (Wells Fargo), $250 (TD Cowen and Rosenblatt), $245 (JPMorgan), and $212 (Morgan Stanley). Aggregator estimates independently cluster in a similar zone, with S&P Global's poll of roughly 43 analysts showing an average near $273 and a full range of about $125 to $500.

The spread is telling. Bulls argue the data-center and AI opportunity justifies premium multiples, while cautious voices emphasize a handset-driven royalty slowdown. Morgan Stanley's $212 target, the lowest among recent marks, sits only modestly above the current price, whereas Mizuho's $330 reflects a far more aggressive view of Arm's silicon strategy. This dispersion means the $275 figure is a statistical midpoint, not a consensus forecast or a guarantee. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

After reporting fiscal second-quarter results, ARM traded near $174.62, down sharply from its 52-week high of $452.70 and still well above its 52-week low of $100.02. Reaching $275 would require a gain of roughly 57%, a very large move even for a volatile semiconductor name.

The path would likely depend on two re-accelerations. First, royalty growth, which slowed to about 8% in the latest quarter with management guiding "low single digits" for the December quarter, would need to recover as smartphone demand stabilizes. Second, the company's new Arm AGI CPU would need to begin contributing measurable revenue, validating the premium multiple. In the most recent quarter, revenue rose 27% to $1.44 billion and adjusted EPS reached $0.52, beating guidance, but the royalty shortfall overshadowed the beat.

What Could Support a Move Toward the Target

Arm's strongest verified tailwinds are structural. License and other revenue jumped 50% to $773 million, reflecting strong demand for its architecture. Data-center royalties doubled year over year, and Arm-based processors now power more than half of major cloud-service deployments, a share management expects to exceed 60% by the end of 2026. The Arm AGI CPU, its first silicon product with Meta as a lead partner, carries a roughly $2 billion revenue target across fiscal 2027 and 2028 and a longer-term $15 billion ambition by fiscal 2031. Valuation has also cooled: the stock's forward P/E ratio has fallen below its three-year average, which could make further gains easier if growth resumes.

What Could Prevent the Target From Being Reached

The principal obstacle is royalty deceleration. Smartphone chips accounted for roughly 43% of fiscal 2026 royalty revenue, and higher memory prices have pressured handset volumes, with peer Qualcomm reporting a 26% decline in handset revenue. Arm still trades at a demanding valuation of roughly 76 times forward earnings and around 200 times trailing earnings, leaving little room for error. An unresolved legal dispute with Qualcomm over royalty payments, dependence on majority owner SoftBank for a meaningful share of licensing revenue, and broader sector volatility tied to data-center restrictions and interest-rate expectations all add risk. Any of these could compress the multiple faster than fundamentals can justify.

Technical Levels and Market Structure

Arm's market structure reflects a steep multi-month decline from its June peak. The $200 round-number level and the band from roughly $212 to $250, where several cautious analyst targets and prior breakdown zones sit, represent the first meaningful resistance on any recovery toward $275. On the downside, the $160-to-$170 zone, which the stock tested after earnings, is a near-term support area, with the 52-week low near $100 acting as the deeper floor. The stock remains in a clear long-term downtrend from its high, meaning a move to $275 would require first reclaiming multiple lower levels.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a research horizon of about 12 months, though individual firms apply different assumptions about royalty recovery and AGI CPU revenue. Investors focused on the $275 question should watch Nvidia's mid-November earnings for commentary on its Arm-based Vera CPU, Arm's early-2026 report for any reacceleration in royalties, AGI CPU production and margin disclosures, and any ruling in the Qualcomm dispute. Analyst revisions after each print will signal whether the mean target is drifting toward the bulls or the bears.

Using Tickeron’s AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, track existing positions, and spot emerging trends more efficiently than manual screening. For a name as volatile as Arm, automated signal monitoring can help filter short-term noise from genuine directional shifts. I find these signals helpful when reviewing names like this one alongside my own analysis.

Final Assessment

The $275 target is a calculated average of recent analyst marks, not a forecast, and reaching it would require a roughly 57% advance from current levels—an outcome that hinges on royalty growth recovering and the Arm AGI CPU ramping on schedule. The bull case rests on durable data-center momentum and a cooling valuation, while the bear case points to a still-expensive multiple and a soft smartphone cycle. With targets spread from $212 to $330, and the broader analyst range from $125 to $500, investor disagreement remains extreme. The next royalty print and AGI CPU milestones will be the clearest signals of whether the path toward $275 is opening or closing.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ARM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ARM's Stochastic Oscillator sits in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +5.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARM advanced for three days, in 182 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

ARM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARM as a result. In 35 of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for ARM turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In 22 of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

ARM moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ARM crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for ARM entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. ARM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ARM's P/B Ratio (21.610) is very high in comparison to the industry average of (5.443). ARM has a moderately high P/E Ratio (178.184) as compared to the industry average of (15.640). Projected Growth (PEG Ratio) (2.327) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (50.761) is also within normal values, averaging (46.468).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI), Marvell Technology (NASDAQ:MRVL).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 180.14B. The market cap for tickers in the group ranges from 86.8K to 4.51T. NVDA holds the highest valuation in this group at 4.51T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was -10%. For the same Industry, the average monthly price growth was -28%, and the average quarterly price growth was -32%. LSCC experienced the highest price growth at 13%, while MRVL experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -25%. For the same stocks of the Industry, the average monthly volume growth was 75% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 52
Price Growth Rating: 67
SMR Rating: 72
Profit Risk Rating: 80
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Industry
N/A
Address
110 Fulbourn Road
Phone
+44 1223400400
Employees
9584
Web
https://www.arm.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
LRCX stock surged +24% over the last 30 days, driven primarily by a strong Q3 fiscal 2026 earnings beat with revenue up 24% year-over-year to $5.84 billion and adjusted EPS of $1.47, exceeding estimates. Over the past quarter, the stock rose +22%, reflecting sustained AI-driven demand for semiconductor manufacturing equipment amid robust wafer fabrication equipment (WFE) spending forecasts.
ABT stock declined approximately -14% over the past 30 days, driven primarily by a post-earnings sell-off following Q1 results and lowered full-year profit guidance due to the Exact Sciences acquisition. Over the past quarter, the stock fell around -20%, reflecting broader pressures from weaker nutrition and diagnostics segments amid a challenging respiratory season.